Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bristol-Myers Squibb
Epidermal Growth Factor Receptor (EGFR), Anaplastic Lymphoma Kinase (ALK)
\*\*Please note that the study is no longer enrolling patients for Groups A, B, C, and E.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com
Histologically confirmed locally advanced or stage IV NSCLC
Eastern Cooperative Oncology Group (ECOG) Performance status (PS) 0-2
Tumor tissue sections must be available for biomarker evaluation
You may not be if
Untreated or active/progressing Central Nervous system (CNS) metastases
Active, known or suspected autoimmune disease
Known history of testing positive for HIV or AIDS
Active or chronic infection of hepatitis B virus or hepatitis C
Clareo Health | A Study of Nivolumab in Advanced Non-Small Cell Lung Cancer (NSCLC)
